Yanju Liu

Area of research

Complementary and alternative medicine · Molecular Biology

Research interest

Research focused on Doxorubicin and Mesenchymal stem cell, with related work in Inflammasome, Apoptosis, Cell biology. Notable publications include 'Doxorubicin Caused Apoptosis of Mesenchymal Stem Cells via p38, JNK and p53 Pathway', 'Mesenchymal Stem Cells and Cardiomyocytes Interplay to Prevent Myocardial Hypertrophy', and 'Polygala tenuifolia willd. Extract alleviates LPS-induced acute lung injury in rats via TLR4/NF-κB pathway and NLRP3 inflammasome suppression'.

h-index

—

citations

works

NIH funding

—

primary concept

—

✉ Find email ↗

Recent publications

Polygala tenuifolia willd. Extract alleviates LPS-induced acute lung injury in rats via TLR4/NF-κB pathway and NLRP3 inflammasome suppression

Phytomedicine 2024cited by 30position: middledoi

Mesenchymal Stem Cells and Cardiomyocytes Interplay to Prevent Myocardial Hypertrophy

Stem Cells Translational Medicine 2015cited by 44position: middledoi

Doxorubicin Caused Apoptosis of Mesenchymal Stem Cells via p38, JNK and p53 Pathway

Cellular Physiology and Biochemistry 2013cited by 53position: middledoi

Grants

No grants ingested yet.

Frequent collaborators

Looking for a research collaborator?

Search millions of scientists by field, institution, impact, and funding status — see their work, find their email, and reach out directly.

Find collaborators in Complementary and alternative medicine · Molecular Biology →